Cargando…

Fulminant myocarditis and cardiogenic shock during SARS-CoV-2 infection()

Detalles Bibliográficos
Autores principales:	Lozano Gómez, Herminia, Pascual Bielsa, Ana, Arche Banzo, Maria José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier España, S.L.U. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603987/ https://www.ncbi.nlm.nih.gov/pubmed/33163627 http://dx.doi.org/10.1016/j.medcle.2020.07.012

Ejemplares similares

Miocarditis fulminante y shock cardiogénico en el curso de infección por SARS-CoV-2
por: Lozano Gómez, Herminia, et al.
Publicado: (2020)

Fulminant Myocarditis With ST Elevation and Cardiogenic Shock in a SARS-CoV-2 Patient
por: Ghafoor, Khuzema, et al.
Publicado: (2021)

Acute necro-hemorrhagic pancreatitis during SARS-CoV-2 infection()
por: Arche Banzo, María José, et al.
Publicado: (2022)

SARS-CoV-2: a potential novel etiology of fulminant myocarditis
por: Chen, Chen, et al.
Publicado: (2020)

Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2019)

Cardiogenic Shock in COVID 19 Fulminant Myocarditis Treated with V-A ECMO
por: D'Errico Ramirez, A., et al.
Publicado: (2022)

Pancreatitis aguda necrohemorrágica durante la infección por SARS-CoV-2
por: Arche Banzo, María José, et al.
Publicado: (2022)

Myocarditis due to systemic lupus erythematosus associated with cardiogenic shock
por: Tariq, Sohaib, et al.
Publicado: (2017)

Elasomeran: Acute fulminant lymphocytic myocarditis and cardiogenic shock: case report
Publicado: (2022)

An Undetected Pheochromocytoma Leading to Fulminant Adrenergic Myocarditis Complicated by Cardiogenic Shock
por: Tran, Nam Q, et al.
Publicado: (2023)

SARS-CoV-2 Fulminant Myocarditis
por: Garot, Jérôme, et al.
Publicado: (2020)

Fulminant Giant Cell Myocarditis and Cardiogenic Shock: An Unusual Presentation of Malignant Thymoma
por: Koul, Deepak, et al.
Publicado: (2010)

Short-term use of “ECMELLA” in the context of fulminant eosinophilic myocarditis with cardiogenic shock
por: Bohné, Mintje, et al.
Publicado: (2020)

Efficacy of central extracorporeal life support for patients with fulminant myocarditis and cardiogenic shock
por: Tadokoro, Naoki, et al.
Publicado: (2021)

Fulminant myocarditis and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

Fulminant myocarditis and COVID-19. Response
por: Irabien-Ortiz, Ángela, et al.
Publicado: (2020)

Cardiogenic shock due to probable SARS-CoV-2 myocarditis—a case report
por: Klasen, Martiene, et al.
Publicado: (2023)

Fulminant myocarditis as an early presentation of SARS-CoV-2
por: Naneishvili, Tamara, et al.
Publicado: (2020)

Biventricular impella (BiPella) utilization in fulminant COVID-19 myopericarditis-mediated cardiogenic shock during pregnancy
por: Srichawla, Bahadar S., et al.
Publicado: (2023)

SARS‐CoV‐2‐related Multisystem Inflammatory Syndrome in Adult complicated by myocarditis and cardiogenic shock
por: De Smet, M.A.J., et al.
Publicado: (2022)

Fulminant cardiogenic shock due to cardiac sarcoidosis
por: Genovese, Leonard, et al.
Publicado: (2021)

Statins for Patients with Cardiogenic Shock
por: Champion, Sébastien
Publicado: (2014)

Acute fulminant eosinophilic myocarditis due to Giardia lamblia infection
por: Beuy, Joob, et al.
Publicado: (2019)

Heart Transplantation to Fulminant Myocarditis during COVID-19 Outbreak
por: Wiwanitkit, Viroj
Publicado: (2020)

Fulminant myocarditis in COVID-19 and favorable outcomes with VA-ECMO
por: Bhardwaj, Abhishek, et al.
Publicado: (2022)

The Clinical Potential of Impella 5.0 Support in the Treatment of Recurrent Fulminant Viral Myocarditis with Profound Cardiogenic Shock
por: Ogawa, Shou, et al.
Publicado: (2019)

Acute fulminant eosinophilic myocarditis due to Giardia lamblia infection presented with cardiogenic shock in a young patient
por: Avşar, Şahin, et al.
Publicado: (2019)

Fulminant Influenza A myocarditis in a patient presenting with cardiogenic shock and biventricular thrombi: a case report
por: Cottet, Mylène, et al.
Publicado: (2022)

Impact of mechanical circulatory support and immunomodulation therapy on outcome of patients with fulminant myocarditis: Chinese registry of fulminant myocarditis
por: Zhou, Ning, et al.
Publicado: (2021)

Myocarditis in the era of SARS-CoV-2: one piece of a complex puzzle?
por: Polito, Maria Vincenza, et al.
Publicado: (2020)

SARS-CoV-2 associated polyradiculitis and myocarditis may favour Takotsubo syndrome
por: Finsterer, Josef, et al.
Publicado: (2021)

SARS-CoV-2 vaccination for unexpected death from atrial myocarditis: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Author's Reply to Heart Transplantation to Fulminant Myocarditis during COVID-19 Outbreak
por: Kim, In-Cheol, et al.
Publicado: (2020)

Postcardiotomy VA-ECMO for refractory cardiogenic shock
por: Charlesworth, Michael, et al.
Publicado: (2017)

Fulminant Myocarditis and Cardiogenic Shock Following COVID-19 Infection Versus COVID-19 Vaccination: A Systematic Literature Review
por: Guglin, Maya E., et al.
Publicado: (2023)

Perimyocardial Injury Specific for SARS-CoV-2-Induced Myocarditis in Comparison With Non-COVID-19 Myocarditis: A Multicenter CMR Study
por: Haberka, Maciej, et al.
Publicado: (2022)

Potentially irreversible olfactory and gustatory impairments in COVID-19: Indolent vs. fulminant SARS-CoV-2 neuroinfection
por: Vavougios, George D.
Publicado: (2020)

Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways
por: Rajpal, Saurabh, et al.
Publicado: (2022)

Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways
por: Rajpal, Saurabh, et al.
Publicado: (2022)

Apical Ballooning and Cardiogenic Shock in Obstructive Hypertrophic Cardiomyopathy
por: Sherrid, Mark V., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_glprj5gu0slb85v4vh5ag3232u